KY19382 is a potent and orally active dual inhibitor of CXXC5-DVL and GSK3β. KY19382 activates Wnt/β-catenin signaling through inhibition of CXXC5-DVL interaction and GSK3β activity. KY19382 can be used in the study of metabolic diseases induced by high fat diet (HFD).
- Size: 1mg
- Purity: ≥98%
- Brand: Saint Michael
- Catalogue No.: IK1610-1mg
For laboratory research use only. Not for human or animal consumption, diagnostic or therapeutic use.
Write Your Own Review